315 related articles for article (PubMed ID: 26763377)
1. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.
Gurka MK; Pender D; Chuong P; Fouts BL; Sobelov A; McNally MW; Mezera M; Woo SY; McNally LR
J Control Release; 2016 Jun; 231():60-7. PubMed ID: 26763377
[TBL] [Abstract][Full Text] [Related]
2. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.
Samykutty A; Grizzle WE; Fouts BL; McNally MW; Chuong P; Thomas A; Chiba A; Otali D; Woloszynska A; Said N; Frederick PJ; Jasinski J; Liu J; McNally LR
Biomaterials; 2018 Nov; 182():114-126. PubMed ID: 30118979
[TBL] [Abstract][Full Text] [Related]
3. Acidic pH-targeted chitosan capped mesoporous silica coated gold nanorods facilitate detection of pancreatic tumors via multispectral optoacoustic tomography.
Zeiderman MR; Morgan DE; Christein JD; Grizzle WE; McMasters KM; McNally LR
ACS Biomater Sci Eng; 2016 Jul; 2(7):1108-1120. PubMed ID: 28626793
[TBL] [Abstract][Full Text] [Related]
4. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1.
Kimbrough CW; Hudson S; Khanal A; Egger ME; McNally LR
J Surg Res; 2015 Jan; 193(1):246-54. PubMed ID: 25439222
[TBL] [Abstract][Full Text] [Related]
6. Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release.
Ryplida B; Lee G; In I; Park SY
Biomater Sci; 2019 May; 7(6):2600-2610. PubMed ID: 30984942
[TBL] [Abstract][Full Text] [Related]
7. Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.
Kimbrough CW; Khanal A; Zeiderman M; Khanal BR; Burton NC; McMasters KM; Vickers SM; Grizzle WE; McNally LR
Clin Cancer Res; 2015 Oct; 21(20):4576-85. PubMed ID: 26124201
[TBL] [Abstract][Full Text] [Related]
8. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment.
Qi G; Shi G; Wang S; Hu H; Zhang Z; Yin Q; Li Z; Hao L
Int J Nanomedicine; 2023; 18():7133-7147. PubMed ID: 38054080
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
[TBL] [Abstract][Full Text] [Related]
10. Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography.
Hudson SV; Huang JS; Yin W; Albeituni S; Rush J; Khanal A; Yan J; Ceresa BP; Frieboes HB; McNally LR
Cancer Res; 2014 Nov; 74(21):6271-9. PubMed ID: 25217521
[TBL] [Abstract][Full Text] [Related]
11. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
Lohiya G; Katti DS
Carbohydr Polym; 2022 Feb; 277():118822. PubMed ID: 34893239
[TBL] [Abstract][Full Text] [Related]
12. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
[TBL] [Abstract][Full Text] [Related]
13. Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography.
Yin W; Kimbrough CW; Gomez-Gutierrez JG; Burns CT; Chuong P; Grizzle WE; McNally LR
J Nanobiotechnology; 2015 Dec; 13():90. PubMed ID: 26627455
[TBL] [Abstract][Full Text] [Related]
14. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
[TBL] [Abstract][Full Text] [Related]
15. Development of Mesoporous Silica Nanoparticles of Tunable Pore Diameter for Superior Gemcitabine Drug Delivery in Pancreatic Cancer Cells.
Saini K; Prabhuraj RS; Bandyopadhyaya R
J Nanosci Nanotechnol; 2020 May; 20(5):3084-3096. PubMed ID: 31635652
[TBL] [Abstract][Full Text] [Related]
16. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
17. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
[TBL] [Abstract][Full Text] [Related]
18. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-modified chitosan-capped mesoporous silica nanoparticles for co-delivery of cytarabine and daunorubicin in leukemia.
Heydari SR; Ghahremani MH; Atyabi F; Bafkary R; Jaafari MR; Dinarvand R
Int J Pharm; 2023 Nov; 646():123495. PubMed ID: 37806507
[TBL] [Abstract][Full Text] [Related]
20. Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT).
Beziere N; Lozano N; Nunes A; Salichs J; Queiros D; Kostarelos K; Ntziachristos V
Biomaterials; 2015 Jan; 37():415-24. PubMed ID: 25453969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
